US Patent 7842661 Glycopegylated erythropoietin formulations
Patent 7842661 was granted and assigned to Novo Nordisk on November, 2010 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
May 25, 2006
0
Date of Patent
November 30, 2010
0
Patent Application Number
11440839
0
Patent Inventor Names
Walter Scott Willett
0
Jichao Kang
0
Robert J. Bayer
0
Shawn DeFrees
0
David A. Zopf
0
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 7842661 Glycopegylated erythropoietin formulations
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
